Needle phobia: confronting a neglected factor in travel vaccine hesitancy.

BACKGROUND: Patients with needle phobia present with disproportionate fear, anxiety, or avoidance of needles that can disrupt access to healthcare services. Needle phobia creates a barrier to public health measures including travel vaccine uptake. This narrative review analyses these challenges by examining the psychological, sociocultural, and clinical determinants of needle phobia and how they can be addressed in travel medicine practice. METHODS: The literature search was performed using PubMed, Scopus, and Google Scholar databases. Only articles published in English were included, with a focus on work published in the last 10 years to align with advancements in vaccine technology and psychological interventions for needle phobia. Key data extracted from studies included population characteristics, prevalence and severity of needle phobia, intervention strategies, vaccine hesitancy trends, and emerging vaccine technologies. RESULTS: Individuals with needle phobia are twice as likely to be vaccine hesitant as non-phobic individuals. Needle phobia often originates from a learned fear response, with 62-81% beginning in childhood, decreases with age, and has a higher prevalence among females (up to two-fold). Prior fainting is more than twice as common in travellers who fear injections (16.5% vs 6.9%). Therapeutic support includes pain management techniques that minimise the physical and psychological discomfort associated with vaccination, distraction interventions, graduated exposure therapy, and applied tension that counteracts vasovagal syncope by using muscle tension techniques. Non-injection vaccine modalities such as oral, intranasal, and microarray patch vaccines may alleviate needle phobia and enhance vaccine compliance. Advances in vaccination technology have the potential to revolutionise how vaccines are administered in travel medicine practice. CONCLUSIONS: Needle phobia represents a significant and often overlooked barrier to vaccine uptake. Addressing this issue requires the integration of both clinical and psychological interventions, along with the adoption of promising technological advancements in vaccine delivery.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-14
DOI
https://doi.org/10.1093/jtm/taag107
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Needle phobia: confronting a neglected factor in travel vaccine hesitancy.

Gerard Thomas Flaherty, Lin Hwei Chen, Aonghus J. Feeney, Mary T McAuliffe
PubMed
Vaccine Coverage and Hesitancy
article

Needle phobia: confronting a neglected factor in travel vaccine hesitancy.

Gerard Thomas Flaherty, Lin Hwei Chen, Aonghus J. Feeney, Mary T McAuliffe
article en

Abstract

BACKGROUND: Patients with needle phobia present with disproportionate fear, anxiety, or avoidance of needles that can disrupt access to healthcare services. Needle phobia creates a barrier to public health measures including travel vaccine uptake. This narrative review analyses these challenges by examining the psychological, sociocultural, and clinical determinants of needle phobia and how they can be addressed in travel medicine practice. METHODS: The literature search was performed using PubMed, Scopus, and Google Scholar databases. Only articles published in English were included, with a focus on work published in the last 10 years to align with advancements in vaccine technology and psychological interventions for needle phobia. Key data extracted from studies included population characteristics, prevalence and severity of needle phobia, intervention strategies, vaccine hesitancy trends, and emerging vaccine technologies. RESULTS: Individuals with needle phobia are twice as likely to be vaccine hesitant as non-phobic individuals. Needle phobia often originates from a learned fear response, with 62-81% beginning in childhood, decreases with age, and has a higher prevalence among females (up to two-fold). Prior fainting is more than twice as common in travellers who fear injections (16.5% vs 6.9%). Therapeutic support includes pain management techniques that minimise the physical and psychological discomfort associated with vaccination, distraction interventions, graduated exposure therapy, and applied tension that counteracts vasovagal syncope by using muscle tension techniques. Non-injection vaccine modalities such as oral, intranasal, and microarray patch vaccines may alleviate needle phobia and enhance vaccine compliance. Advances in vaccination technology have the potential to revolutionise how vaccines are administered in travel medicine practice. CONCLUSIONS: Needle phobia represents a significant and often overlooked barrier to vaccine uptake. Addressing this issue requires the integration of both clinical and psychological interventions, along with the adoption of promising technological advancements in vaccine delivery.

PubMed
Mount Auburn Hospital (US), Harvard University (US), Ollscoil na Gaillimhe – University of Galway (IE), Mahidol University (TH), British Association for Behavioural and Cognitive Psychotherapies (GB), IMU University (MY)
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon